propranolol has been researched along with Agoraphobia in 13 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Agoraphobia: Obsessive, persistent, intense fear of open places.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifty-five patients completed a 5-week double-blind study comparing alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks." | 9.06 | Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks. ( Brown, R; Cabe, D; Crocker, B; Leonard, M; McDowell, D; McManus, M; Munjack, DJ; Palmer, R; Usigli, R; Zulueta, A, 1989) |
| "The response to diazepam and propranolol hydrochloride was compared in 21 patients who (with one exception) met DSM-III criteria for panic disorder and agoraphobia." | 9.05 | Diazepam and propranolol in panic disorder and agoraphobia. ( Anderson, DJ; Clancy, J; Crowe, RR; Ghoneim, MM; Hinrichs, JV; Noyes, R; Slymen, DJ, 1984) |
| "The effects of oral doses of diazepam (single dose of 10 mg and a median dose of 30 mg/day for 2 weeks) and propranolol (single dose of 80 mg and a median dose of 240 mg/day for 2 weeks) on psychological performance of patients with panic disorders and agoraphobia were investigated in a double-blind, randomized and crossover design." | 9.05 | Behavioral effects of diazepam and propranolol in patients with panic disorder and agoraphobia. ( Anderson, DJ; Ghoneim, MM; Hinrichs, JV; Noyes, R, 1984) |
| "We studied the efficacy of propranolol (Inderal) compared to alprazolam (Xanax) in 29 patients with a diagnosis of agoraphobia with panic disorder or panic disorder with or without limited phobic avoidance in a 6-week double-blind controlled experiment." | 5.07 | A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients. ( Friedman, MJ; Hauri, PJ; McHugo, GJ; Ravaris, CL, 1991) |
| "Fifty-five patients completed a 5-week double-blind study comparing alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks." | 5.06 | Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks. ( Brown, R; Cabe, D; Crocker, B; Leonard, M; McDowell, D; McManus, M; Munjack, DJ; Palmer, R; Usigli, R; Zulueta, A, 1989) |
| "The response to diazepam and propranolol hydrochloride was compared in 21 patients who (with one exception) met DSM-III criteria for panic disorder and agoraphobia." | 5.05 | Diazepam and propranolol in panic disorder and agoraphobia. ( Anderson, DJ; Clancy, J; Crowe, RR; Ghoneim, MM; Hinrichs, JV; Noyes, R; Slymen, DJ, 1984) |
| "The effects of oral doses of diazepam (single dose of 10 mg and a median dose of 30 mg/day for 2 weeks) and propranolol (single dose of 80 mg and a median dose of 240 mg/day for 2 weeks) on psychological performance of patients with panic disorders and agoraphobia were investigated in a double-blind, randomized and crossover design." | 5.05 | Behavioral effects of diazepam and propranolol in patients with panic disorder and agoraphobia. ( Anderson, DJ; Ghoneim, MM; Hinrichs, JV; Noyes, R, 1984) |
| " Among the more important recent discoveries are the efficacy of the tricyclic antidepressants for panic disorder and agoraphobia with panic attacks; the use of the monoamine oxidase inhibitors for the above disorders and for atypical depression and hysteroid dysphoria; the use of propranolol for anxiety disorders and for uncontrollable violent outbursts; the antianxiety and antipanic effects of clonidine; and the usefulness of lithium in treating schizophrenia and schizoaffective disorder and for emotionally unstable character disorders." | 4.76 | Newer uses for older psychotropic medications. ( Liebowitz, MR, 1982) |
| "Ten cases are presented--two in detail--in which clonazepam was used successfully in patients with treatment-resistant panic disorder with or without agoraphobia." | 3.67 | Successful use of clonazepam in patients with treatment-resistant panic disorder. ( Rosenbaum, JF; Tesar, GE, 1986) |
| "Panic disorder is characterised by recurrent unexpected panic attacks consisting of a wave of intense fear that reaches a peak within a few minutes." | 2.61 | Benzodiazepines versus placebo for panic disorder in adults. ( Barbui, C; Bighelli, I; Breilmann, J; Castellazzi, M; Cipriani, A; Davies, SJ; Furukawa, TA; Girlanda, F; Guaiana, G; Koesters, M, 2019) |
| "Propranolol was effective in treating acute pathological panic, but modest doses of the drug administered for brief periods of time did not alleviate chronic panic attacks associated with agoraphobia." | 1.26 | The treatment of pathological panic states with propranolol. ( Defrancisco, D; Heiser, JF, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (76.92) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breilmann, J | 1 |
| Girlanda, F | 1 |
| Guaiana, G | 1 |
| Barbui, C | 1 |
| Cipriani, A | 1 |
| Castellazzi, M | 1 |
| Bighelli, I | 1 |
| Davies, SJ | 1 |
| Furukawa, TA | 1 |
| Koesters, M | 1 |
| Liebowitz, MR | 2 |
| Gorman, JM | 1 |
| Levy, GF | 1 |
| McGrath, P | 1 |
| Appleby, IL | 1 |
| Dillon, DJ | 1 |
| Davies, SO | 1 |
| Klein, DF | 1 |
| Noyes, R | 2 |
| Anderson, DJ | 2 |
| Clancy, J | 1 |
| Crowe, RR | 1 |
| Slymen, DJ | 1 |
| Ghoneim, MM | 2 |
| Hinrichs, JV | 2 |
| Hafner, J | 1 |
| Milton, F | 1 |
| Heiser, JF | 1 |
| Defrancisco, D | 1 |
| Ravaris, CL | 1 |
| Friedman, MJ | 1 |
| Hauri, PJ | 1 |
| McHugo, GJ | 1 |
| Yeragani, VK | 1 |
| Pohl, R | 1 |
| Balon, R | 1 |
| Aronson, TA | 1 |
| Carasiti, I | 1 |
| McBane, D | 1 |
| Whitaker-Azmitia, P | 1 |
| Munjack, DJ | 1 |
| Crocker, B | 1 |
| Cabe, D | 1 |
| Brown, R | 1 |
| Usigli, R | 1 |
| Zulueta, A | 1 |
| McManus, M | 1 |
| McDowell, D | 1 |
| Palmer, R | 1 |
| Leonard, M | 1 |
| Griez, E | 1 |
| van den Hout, MA | 1 |
| Tesar, GE | 1 |
| Rosenbaum, JF | 1 |
2 reviews available for propranolol and Agoraphobia
| Article | Year |
|---|---|
Benzodiazepines versus placebo for panic disorder in adults.
Topics: Adult; Aged; Agoraphobia; Benzodiazepines; Buspirone; Humans; Imipramine; Middle Aged; Numbers Neede | 2019 |
Newer uses for older psychotropic medications.
Topics: Adrenergic beta-Antagonists; Agoraphobia; Anxiety Disorders; Bipolar Disorder; Clonidine; Depressive | 1982 |
6 trials available for propranolol and Agoraphobia
| Article | Year |
|---|---|
Diazepam and propranolol in panic disorder and agoraphobia.
Topics: Adult; Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Depression; Diazepam; Double-Blind | 1984 |
Behavioral effects of diazepam and propranolol in patients with panic disorder and agoraphobia.
Topics: Adult; Agoraphobia; Clinical Trials as Topic; Cognition; Diazepam; Double-Blind Method; Fear; Female | 1984 |
The influence of propranolol on the exposure in vivo of agoraphobics.
Topics: Adult; Agoraphobia; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Heart | 1977 |
A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.
Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Double-Blind Method; Female; Humans; Male; Middle Aged; | 1991 |
Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Clinical Trials as Topic; Double-Blind Method; Fear; Fem | 1989 |
CO2 inhalation in the treatment of panic attacks.
Topics: Adolescent; Adult; Agoraphobia; Carbon Dioxide; Fear; Female; Follow-Up Studies; Humans; Male; Middl | 1986 |
5 other studies available for propranolol and Agoraphobia
| Article | Year |
|---|---|
Effect of acute beta-adrenergic blockade on lactate-induced panic.
Topics: Adult; Agoraphobia; Blood Pressure; Fear; Female; Heart Rate; Humans; Lactates; Lactic Acid; Male; M | 1983 |
The treatment of pathological panic states with propranolol.
Topics: Acute Disease; Adult; Agoraphobia; Anxiety Disorders; Chronic Disease; Depression; Depressive Disord | 1976 |
Lactate-induced panic and beta-adrenergic blockade.
Topics: Adult; Agoraphobia; Arousal; Dose-Response Relationship, Drug; Fear; Female; Heart Rate; Humans; Inf | 1990 |
Biological correlates of lactate sensitivity in panic disorder.
Topics: Adult; Agoraphobia; Arousal; Dihydroalprenolol; Fear; Female; Heart Rate; Humans; Hydrocortisone; La | 1989 |
Successful use of clonazepam in patients with treatment-resistant panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Clonazepam; D | 1986 |